Last reviewed · How we verify
NCT06261216
Association Between Lifetime Physical Activity and Exercise and the Development of Wild-type Transthyretin Amyloid Cardiomyopathy
trial testing Interview in Amyloid Cardiomyopathy in 180 participants. Completed in 20 November 2025.
20 November 2025
Quick facts
| Lead sponsor | Medical University of Graz |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 180 |
| Start date | 16 February 2024 |
| Primary completion | 20 November 2025 |
| Estimated completion | 20 November 2025 |
| Sites | 1 location across Austria |
Drugs / interventions tested
- Interview
Conditions studied
- Amyloid Cardiomyopathy — all drugs for Amyloid Cardiomyopathy →
- Wild Type ATTR Amyloidosis — all drugs for Wild Type ATTR Amyloidosis →
Sponsor
Medical University of Graz
Who can join
60 and older, any sex, with Amyloid Cardiomyopathy or Wild Type ATTR Amyloidosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to investigate the association between increased lifetime physical activity and the development of wild-type transthyretin amyloid cardiomyopathy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06261216
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Interview
Trials testing the same drug.
- NCT07377006 — Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer · NA · not yet recruiting
- NCT07226102 — Virtual Mental Health Intervention to Address Fear of Progression for Women With High Risk or Stage III-IV Gynecologic o · NA · withdrawn
- NCT07225855 — Geriatric Assessment and Management for Older Adults Undergoing Chemotherapy and Radiation Therapy for Head and Neck Can · NA · not yet recruiting
- NCT07282444 — A New Way to Share Radiation Therapy Plans Between Doctors, CORRECT Trial · NA · not yet recruiting
- NCT07490860 — A Restorative Justice-Based Lung Cancer Screening Decision-Making Support Intervention Tailored for Black Individuals to · NA · not yet recruiting
Other recruiting trials for Amyloid Cardiomyopathy
Currently open trials in the same condition.
- NCT07382128 — Myocardial Perfusion CMR for Differentiating and Characterizing Hypertrophic Cardiomyopathy Phenotypes · recruiting
- NCT06634108 — Genistein in trAnSthyretin recePtor Amyloid caRdiomyopathy · Phase 1, PHASE2 · recruiting
- NCT05797857 — Exercise Training in Transthyretin Cardiac Amyloidosis · NA · recruiting
- NCT05103943 — Amyloidosis TTR Flow Reserve Evaluation · NA · active not recruiting
- NCT04776824 — Swiss Cardiac Amyloidosis REgistry (Swiss-CARE) · recruiting
Other Medical University of Graz trials
Trials by the same sponsor.
- NCT07498244 — Collagen Fingerprinting for Stratification of Pulmonary Hypertension (PH) Patients · recruiting
- NCT07492823 — Clinical Applicability of Liquid Biopsy in Chondrosarcoma · not yet recruiting
- NCT07297615 — 3D Liver Volumetry · NA · not yet recruiting
- NCT07588282 — The Effect of Psychoeducational Diagnosis Communication on Perception of Illness, Satisfaction, and Behavioral Intention · NA · recruiting
- NCT07376096 — Liquid Biopsy in Germ Cell Tumors · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06261216 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medical University of Graz
- Last refreshed: 9 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06261216.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing